State of Alaska Department of Revenue’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$20.1M Sell
45,255
-1,250
-3% -$556K 0.22% 73
2025
Q1
$22.5M Buy
46,505
+720
+2% +$349K 0.26% 57
2024
Q4
$18.4M Sell
45,785
-2,190
-5% -$882K 0.21% 74
2024
Q3
$22.3M Sell
47,975
-2,370
-5% -$1.1M 0.24% 69
2024
Q2
$23.6M Buy
50,345
+340
+0.7% +$159K 0.26% 60
2024
Q1
$20.9M Sell
50,005
-2,890
-5% -$1.21M 0.24% 71
2023
Q4
$21.5M Sell
52,895
-500
-0.9% -$203K 0.26% 65
2023
Q3
$18.6M Sell
53,395
-1,255
-2% -$436K 0.23% 72
2023
Q2
$19.2M Sell
54,650
-8,664
-14% -$3.05M 0.23% 72
2023
Q1
$19.9M Buy
63,314
+4
+0% +$1.26K 0.24% 75
2022
Q4
$18.3M Buy
63,310
+6,940
+12% +$2M 0.23% 81
2022
Q3
$16.3M Buy
56,370
+1,598
+3% +$463K 0.22% 90
2022
Q2
$15.4M Buy
54,772
+18,957
+53% +$5.34M 0.19% 99
2022
Q1
$9.35M Sell
35,815
-985
-3% -$257K 0.1% 220
2021
Q4
$8.08M Sell
36,800
-3,035
-8% -$666K 0.08% 299
2021
Q3
$7.23M Sell
39,835
-4,513
-10% -$819K 0.07% 318
2021
Q2
$8.94M Buy
44,348
+3,619
+9% +$730K 0.09% 263
2021
Q1
$8.75M Sell
40,729
-1,812
-4% -$389K 0.1% 259
2020
Q4
$10.1M Sell
42,541
-2,442
-5% -$577K 0.11% 213
2020
Q3
$12.2M Sell
44,983
-10,876
-19% -$2.96M 0.15% 159
2020
Q2
$16.2M Buy
55,859
+11,015
+25% +$3.2M 0.21% 95
2020
Q1
$10.7M Buy
44,844
+879
+2% +$209K 0.17% 153
2019
Q4
$9.63M Sell
43,965
-3,460
-7% -$757K 0.13% 227
2019
Q3
$8.03M Buy
47,425
+6,890
+17% +$1.17M 0.11% 270
2019
Q2
$7.43M Buy
40,535
+153
+0.4% +$28K 0.12% 186
2019
Q1
$7.43M Sell
40,382
-630
-2% -$116K 0.13% 177
2018
Q4
$6.8M Buy
41,012
+64
+0.2% +$10.6K 0.13% 179
2018
Q3
$7.89M Sell
40,948
-82
-0.2% -$15.8K 0.13% 177
2018
Q2
$6.97M Buy
41,030
+5,682
+16% +$966K 0.12% 190
2018
Q1
$5.76M Buy
35,348
+4,270
+14% +$696K 0.12% 197
2017
Q4
$4.66M Buy
31,078
+25,008
+412% +$3.75M 0.11% 213
2017
Q3
$922K Buy
6,070
+4,540
+297% +$690K 0.05% 503
2017
Q2
$197K Buy
+1,530
New +$197K 0.01% 871